Sana Biotechnology, Inc. (NASDAQ:SANA) is held by 197 institutional investors per 13F filings through December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| FMR LLC | 31 Dec, 2025 | 37,430,284 | -1,081 | 0.00% | $152,341,256.00 |
| Flagship Pioneering, LLC | 31 Dec, 2025 | 25,001,856 | 0 | 0.00% | $101,757,555.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 14,223,527 | 2,997,391 | 26.70% | $57,889,754.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 10,455,195 | 1,326,222 | 14.53% | $42,552,645.00 |
| CANADA PENSION PLAN INVESTMENT BOARD | 31 Dec, 2025 | 10,242,100 | 67,100 | 0.66% | $41,685,347.00 |
| State Street Corp | 31 Dec, 2025 | 8,054,841 | 1,374,300 | 20.57% | $32,783,203.00 |
| BAILLIE GIFFORD & CO | 31 Dec, 2025 | 6,609,065 | -4,827,438 | -42.21% | $26,898,895.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 4,118,138 | 694,606 | 20.29% | $16,763,171.00 |
| Marex Group plc | 31 Dec, 2025 | 3,732,780 | -90,000 | -2.35% | $15,192,415.00 |
| Integral Health Asset Management, LLC | 31 Dec, 2025 | 3,000,000 | 1,000,000 | 50.00% | $12,210,000.00 |
| Goldman Sachs Group Inc | 31 Dec, 2025 | 2,976,754 | 2,294,662 | 336.42% | $12,115,388.00 |
| Alphabet Inc. | 31 Dec, 2025 | 2,812,500 | 0 | 0.00% | $11,446,875.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Dec, 2025 | 1,691,116 | -301,384 | -15.13% | $6,882,842.00 |
| BALYASNY ASSET MANAGEMENT L.P. | 31 Dec, 2025 | 1,679,130 | 1,679,130 | 0.00% | $6,834,059.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Dec, 2025 | 1,579,705 | 969,577 | 158.91% | $6,429,399.00 |
| Northern Trust Corp | 31 Dec, 2025 | 1,407,699 | 89,203 | 6.77% | $5,729,336.00 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 31 Dec, 2025 | 1,399,335 | 126,772 | 9.96% | $5,695,293.00 |
| Woodline Partners LP | 31 Dec, 2025 | 1,317,641 | -60,595 | -4.40% | $5,362,799.00 |
| Morgan Stanley | 31 Dec, 2025 | 1,285,045 | 408,540 | 46.61% | $5,230,133.00 |
| Corient Private Wealth LLC | 31 Dec, 2025 | 1,276,734 | 459,734 | 56.27% | $5,196,308.00 |